Skip to main content

Advertisement

SpringerLink
Log in

Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bartalena L, Chiovato L, Vitti P (2016) Management of hyperthyroidism due to Graves’ disease: frequently asked questions and answers (if any). J Endocrinol Invest 39:1105–1114

    Article  CAS  PubMed  Google Scholar 

  2. Sedel F, Papeix C, Bellanger A et al (2015) High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 4(2):159–169

    Article  PubMed  Google Scholar 

  3. Barbesino G (2016) Misdiagnosis of Graves’ disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid 26(6):860–863

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Unit, Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Varese, Italy

    C. Cusini, L. Sassi, G. De Paola & E. Piantanida

Authors
  1. C. Cusini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Sassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. De Paola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Piantanida
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Piantanida.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest or founding.

Ethical approval

All diagnostic and therapeutic procedures performed in this study were in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Patient gave her informed consent for publication.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cusini, C., Sassi, L., De Paola, G. et al. Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis. J Endocrinol Invest 40, 889–890 (2017). https://doi.org/10.1007/s40618-017-0678-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0678-y

Keywords

Search

Navigation